Magnetic levitation pumps for cell-free hemoglobin prevention during VV ECMO

Magnetic levitation pumps for cell-free hemoglobin prevention during VV ECMO

Bibliographic Details
Main Author:	Ignazio Condello
Format:	Article
Language:	English
Published:	BMC 2022-03-01
Series:	Critical Care
Online Access:	https://doi.org/10.1186/s13054-022-03963-9

Similar Items

The role of cell-free hemoglobin and haptoglobin in acute kidney injury in critically ill adults with ARDS and therapy with VV ECMO
by: Jan A. Graw, et al.
Published: (2022-02-01)

Magnetic levitation pump versus constrained vortex pump: a pilot study on the hemolysis effect during minimal invasive extracorporeal circulation
by: Ignazio Condello, et al.
Published: (2021-09-01)

Minimal invasive extracorporeal circulation an alternative to ECMO in ventricular tachycardia ablation
by: Condello Ignazio
Published: (2023-09-01)

Factors associated with hemolysis during extracorporeal membrane oxygenation (ECMO)-Comparison of VA- versus VV ECMO.
by: Hannah Appelt, et al.
Published: (2020-01-01)

Long-term ECMO, efficiency and performance of EUROSETS adult A.L.ONE ECMO oxygenator
by: Ignazio Condello, et al.
Published: (2023-03-01)

Cryotherapy: A Safe Approach to Pulmonary Hemorrhage During VV-ECMO
by: Adam Green MD, et al.
Published: (2022-02-01)

von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO
by: Christian Valladolid, et al.
Published: (2018-08-01)

Impact of CRRT in Patients with PARDS Treated with VV-ECMO
by: Sébastien Redant, et al.
Published: (2021-03-01)

Post VV-ECMO Weaning Hyperinflammation—Can Prophylactic Hemoadsorption Treatment Prevent Complications?
by: Pedja Kovacevic, et al.
Published: (2023-10-01)

Massive hemoptysis bridged with VV ECMO: A case report
by: Dylan Ryan, et al.
Published: (2022-09-01)

Magnetic levitation for down-hole submersible pumps
by: Garcia, Christian Daniel, 1979-
Published: (2012)

Early vvECMO implantation may be associated with lower mortality in ARDS
by: Peter Rosenberger, et al.
Published: (2023-09-01)

VV-ECMO for surgical cure of a critical central airway obstruction
by: Hassan A. Raza, et al.
Published: (2019-01-01)

Successful use of VV-ECMO in a pregnant patient with severe ARDS
by: Laurence Carlier, et al.
Published: (2019-07-01)

Survival following traumatic thoracic compartment syndrome managed with VV-ECMO
by: Timothy Amos, et al.
Published: (2019-12-01)

Secondary pneumomediastinum in COVID-19 patient: A case managed with VV-ECMO
by: Gianlorenzo Golino, et al.
Published: (2024-01-01)

The Prolonged Use of VV ECMO Support in COVID-19: A Case Report
by: Fitzgerald Amelia Lucy, et al.
Published: (2020-11-01)

Favorable outcome with early initiation of VV-ECMO for unilateral lung disease in children
by: Hammad A. Ganatra, et al.
Published: (2019-01-01)

Potential of cell-free hemoglobin and haptoglobin as prognostic markers in patients with ARDS and treatment with veno-venous ECMO
by: Victoria Bünger, et al.
Published: (2023-04-01)

Prognostic value of respiratory compliance course on mortality in COVID-19 patients with vv-ECMO
by: Simon Valentin, et al.
Published: (2023-06-01)

Prone positioning in ARDS patients supported with VV ECMO, what we should explore?
by: Hongling Zhang, et al.
Published: (2022-10-01)

Hemocompatibility of new magnetically-levitated centrifugal pump technology compared to the CentriMag adult pump
by: David Schibilsky, et al.
Published: (2020-12-01)

Axillary vein as an alternative venous access site for VV-ECMO cannulation: a case report
by: Tao Pan, et al.
Published: (2024-03-01)

Analysis of Patients with Severe ARDS on VV ECMO Treated with Inhaled NO: A Retrospective Observational Study
by: Stefan Muenster, et al.
Published: (2024-03-01)

Bleeding Complications in COVID-19 Critically Ill ARDS Patients Receiving VV-ECMO Therapy
by: Armin Niklas Flinspach, et al.
Published: (2023-10-01)

Prolonged time from intubation to cannulation in VV-ECMO for COVID-19: does it really matter?
by: Pierre-Yves Olivier, et al.
Published: (2021-11-01)

Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
by: Zhiheng Xu, et al.
Published: (2021-08-01)

Spontaneous hemothorax in 4 COVID-19 ARDS patients on VV-ECMO revealing pulmonary artery aneurysms
by: Cyrielle Desnos, et al.
Published: (2020-11-01)

A Dedicated Expert ECMO-Team and Strict Patient Selection Improve Survival of Patients with Severe SARS-CoV-2 ARDS Supported by VV-ECMO
by: Raphaël Giraud, et al.
Published: (2022-12-01)

Response to Prone Position in COVID-19 and Non-COVID-19 Patients with Severe ARDS Supported by vvECMO
by: Laura Textoris, et al.
Published: (2023-06-01)

In Vitro and In Vivo Feasibility Study for a Portable VV-ECMO and ECCO<sub>2</sub>R System
by: Lasse J. Strudthoff, et al.
Published: (2022-01-01)

Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome
by: Bruno Garcia, et al.
Published: (2020-07-01)

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) for life-threatening isolated pulmonary anti-GBM disease
by: Shogo Goda, et al.
Published: (2022-01-01)

vvECMO can be avoided by a transpulmonary pressure guided open lung concept in patients with severe ARDS
by: Philip van der Zee, et al.
Published: (2019-04-01)

Magnetic levitation performance of miniaturized magnetically levitated motor with 5-DOF active control
by: Masahiro OSA, et al.
Published: (2017-08-01)

Prevention of Cerebral Lesion in Asymptomatic Carotid and Vertebral Artery Stenosis in Urgent Cardiac Surgery
by: Ignazio Condello, et al.
Published: (2021-06-01)

Perioperative incidence of ECMO and IABP on 5901 mitral valve surgery procedures
by: Ignazio Condello, et al.
Published: (2022-03-01)

Magnetic levitation (magnetic coil development) /
by: 266359 Mohd. Hafiz Mohd. Ghani, et al.
Published: (2008)

Biomedical Applications of Magnetic Levitation
by: Sajjad Rahmani Dabbagh, et al.
Published: (2022-03-01)

Stabilization of the Magnetic Levitation System
by: Štefan Chamraz, et al.
Published: (2021-11-01)